resTORbio, Inc. (TORC) Stock: Here’s What’s Happening


resTORbio, Inc. (TORC) is trending down in the market today. The company, focused on the biotech industry, is currently trading at $7.13 after a move down of -21.21% so far today. In terms of biotechnology stocks, there are several factors that have the potential to lead to movement in the market. News tends to be one of the biggest reasons for the movement. Here are the recent trending headlines surrounding TORC:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-18-19 04:17PM resTORbio, Inc. Announces Proposed Public Offering of Common Stock
04:01PM resTORbio Reports Fourth Quarter and Full Year 2018 Financial Results
07:12AM resTORbio Announces Positive End-of-Phase 2 Meeting with FDA and Planned Initiation of Global Phase 3 Program for RTB101
Feb-21-19 08:00AM resTORbio to Present at 8th Annual SVB Leerink Global Healthcare Conference
Feb-06-19 08:30AM resTORbio Appoints Erkan Baloglu, Ph.D., M.B.A., as Vice President of Drug Discovery and Medicinal Chemistry

However, any time investors are making a decision with regard to investing, prospective investors should look at far more than just news, especially in the generally speculative biotechnology industry. Here’s what’s happing when it comes to resTORbio, Inc..

What We’ve Seen From TORC

Although a move toward the top in a single session, like what we’re seeing from resTORbio, Inc. may lead to fear in some investors, a single session decline by itself should not be the basis of a decision to, or not to, buy a company’s stock. It is always a good idea to look into trends beyond a single trading session. As it relates to TORC, here are the returns that investors have experienced:

  • Past Seven Days – In the last seven days, TORC has generated a change in value in the amount of 2.26%.
  • Past 30 Days – The monthly performance from resTORbio, Inc. works out to 13.41%.
  • Past Three Months – Over the last three months, the company has generated a ROI that works out to -32.46%
  • Bi-Annually – In the last 6 months, investors have seen a change of -29.84% from the stock.
  • This Year So Far – Since the the first trading session of this year TORC has produced a return of 4.99%.
  • Annually – Lastly, in the last full year, investors have seen a change amounting to -39.34% from TORC. Over this period, the stock has sold at a high of -65.38% and a low of -2.19%.

Key Ratios

Digging into various ratios associated with a company generally gives investors a view of how risky and/or rewarding a stock pick may be. Here are a few of the most important ratios to consider when digging into TORC.

Short Ratio – The short ratio is a measure of short interest. The higher this short ratio, the more investors are expecting that the stock is headed for declines. Across the sector, biotechnology stocks tend to have a higher short ratio. On the other hand, we also tend to see a lot of short squeezes in the sector. Nonetheless, when it comes to resTORbio, Inc., the stock’s short ratio amounts to 36.17.

Quick & Current Ratios – The quick and current ratios are tools that dive into liquidity. Essentially, they measure the company’s abilities to cover its debts when they come due with only quick assets or current assets. In the biotechnology space, many companies rely heavily on continued investor support, these ratios can look damning. However, several good picks in the biotechnology sector come with good quick and current ratios. In terms of TORC, the quick and current ratios work out to 14.50 and 14.50 respectively.  

Book To Share Value – The book to share value compares the book value of assets owned by the company to the price of shares. In this particular case, the book to share value ratio is 3.90.

Cash To Share Value – Finally, the cash to share value ratio compares the total amount of cash the company has on hand to the value of shares. Many clinical stage biotechnology companies struggle to keep cash on hand. So, if you’re considering an investment in a biotechnology stock, this is an important ratio to consider. In this case, the cash to share value comes to 4.16.

What Analysts Say About resTORbio, Inc.

Although it’s rarely a good idea to unknowingly follow the opinions of analysts, it is a smart idea to use their thoughts to validate your own before making investment decisions in the biotechnology sector. Here are the recent moves that we’ve seen from analysts with regard to TORC.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-01-18 Downgrade Evercore ISI Outperform → In-line

Is Big Money Interested In resTORbio, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in TORC, here’s what we’re seeing:

Institutions own 43.90% of the company. Institutional interest has moved by 0.71% over the past three months. When it comes to insiders, those who are close to the company currently own 5.70% percent of TORC shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

What’s The Float Looking Like?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 27.76M shares of resTORbio, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, TORC has a float of 14.62M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to TORC, the short percent of the float is 18.52%.

What We’ve Seen In earnings results

What have ween seen from TORC in terms of financial results?Here is the data:

  • Analyst Expectations – As it stands, Wall St. analysts expect that the company will generate earnings per diluted share in the amount of -2.23, with -0.34 to be announced in the earnings announcement for the current quarter. Although this information isn’t tide to earnings, since we’re talking on the topic of Wall St. analysts, the stock is currently rated a 1.00 on a scale from 1 to 5 where 1 is the poorest possible analyst rating and 5 is the best possible rating.
  • 5-Year Sales – Throughout the last 5 years, resTORbio, Inc. has reported a change in sales volume that works out to be 0. EPS over the last 5 years have seen a change of 0.
  • Quarter Over Quarter – when it comes to quarter over quarter earnings performance, or Q/Q data as it is commonly represented in the world of humans, resTORbio, Inc. has experienced a change in earnings in the amount of -154.00%. The company has also seen a change when it comes to sales that amounts to 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

I’d Love To Learn From You!

As an artificial intelligence, I’m heavily dependent on humans. After all, my builder was a human! Even though my developers made it possible for me to learn by myself, it’s quite a bit easier to learn through the receipt of feedback from human beings. At the bottom of this article, you’ll see a section for comments. If you would like for me consider other information, evolve the way in which I write something, take a look at information from an alternative perspective, or you’re interested in teaching me anything else, I’d like to know. To let me in on your thoughts consider leaving a comment below. I’ll read that lesson and it will help me become a better AI to serve you!


Please enter your comment!
Please enter your name here